Respiratory Illnesses in China Not Caused by New Virus, CDC Director Testifies
By Robin Foster HealthDay Reporter
FRIDAY, Dec. 1, 2023 (Healthday News) -- In testimony provided Thursday to members of Congress, the head of the U.S. Centers for Disease Control and Prevention said that a surge in respiratory illnesses in China is not being fueled by a new virus.
Instead, the spike can be linked to existing viruses and bacteria, including COVID-19, the flu, respiratory syncytial virus (RSV) and Mycoplasma pneumonia, CDC Director Dr. Mandy Cohen testified.
Her assessment mirrors the explanation offered by Chinese authorities and reported by the World Health Organization.
"But they are seeing an upsurge. We do have an office, the CDC does, in China,” she testified, NBC News reported. “And our officials have been in touch with our counterparts to ensure that we’re understanding the situation there.”
The surge is concentrated in northern China, she added, where hospitals have been flooded with sick children.
Since mid-October, that region has reported an increase in influenza-like illness compared to the same period in the previous three years, WHO has reported.
The United Nations health agency has asked China to provide more information about the surge in respiratory illnesses, NBC News reported. Both the Chinese government and WHO have faced criticism over a lack of transparency in the early days of the COVID-19 pandemic.
But Chinese officials insist the lifting of the strictest pandemic restrictions late last year has fueled the surge in illnesses, NBC News reported. Such a surge has been seen in other countries that have lifted strict COVID restrictions, including Australia and New Zealand.
Health officials in China say they are working to increase the availability of health care providers and boost the supply of medicine, while advising parents of children with mild cases to avoid going to hospitals because of long wait times and the risk of more infections, NBC News reported.
Sources
- NBC News
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Extended Course of Paxlovid Adds No Benefit for Those With Long COVID
FRIDAY, June 7, 2024 -- An extended course of the antiviral drug Paxlovid won’t ease a person’s Long COVID symptoms, a new study finds. People who took Paxlovid for...
FDA Panel OKs New COVID Vaccine for Fall
THURSDAY, June 6, 2024 -- A U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will...
Long COVID's Toll Outlined in New Report
THURSDAY, June 6, 2024 -- Long COVID continues to plague millions of Americans as the health costs of the pandemic linger four years later, a new report warns. In a hefty...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.